January 09, 2015
We are pleased to report that our work is represented in half of Lexpert’s 10 Top Ten Deals of 2014. The list, according to Lexpert, is compiled “based on an extensive canvass of Canadian M&A, securities and corporate finance lawyers.” Criteria for 2014’s list included significant Canadian legal content and “represent a trend, illustrate some aspect of the year’s economic climate, or be a portent of things to come.”
In Lexpert’s Top Ten Deals of 2014, Torys acted for:
Partners Cornell Wright and Sharon Geraghty were also quoted in the article for insight into the Loblaw and Endo deals, respectively. The article references the merging of iconic Canadian brands in the Loblaw/Shoppers deal—a fact that stirred attention from the Competition Bureau. Cornell comments that “The Competition review was a key factor because both parties knew from the outset that the Bureau would want some stores to be divested and the number would potentially impact the overall economics of the deal. . .The parties worked hard over a long period of time and that was evident in the result.” Sharon provides context on the Endo/Paladin transaction in the article, describing it as “an inversion deal into Ireland using a Canadian target with a public spin out of Knight Pharmaceuticals (which itself has been quite active/successful in its short time as a public company). . .Inversions were the big M&A story this year and this is the deal that brought Canada into that story.”
To learn more about our recent work, click here.
To read the full article, click here.